Cathepsin B is a target of Hedgehog signaling in pancreatic cancer

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 266-272

  Hwang, Jin Hyeok ^a,b   Lee, Sang Hyub ^b   Lee, Kwang Hyuck ^b   Lee, Keung Youp ^a   Kim, Haeryoung ^b   Ryu, Ji Kon ^a   Yoon, Yong Bum ^a   Kim, Yong Tae ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Cathepsin B; Hedgehog gene; Invasion; Pancreatic cancer

Indexed keywords

BETA ACTIN; CATHEPSIN B; CATHEPSIN B INHIBITOR; CYCLOPAMINE; MESSENGER RNA; PROTEIN PATCHED; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CATB GENE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CATHEPSIN B; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 57349193435     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.028     Document Type: Article

References (39)

1. Nusslein-Volhard C., and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980) 795-801
2. Ingham P.W., and McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15 (2001) 3059-3087
3. Mullor J.L., Sanchez P., and Altaba A.R. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 12 (2002) 562-569
4. Chiang C., Litingtung Y., Lee E., Young K.E., Corden J.L., Westphal H., and Beachy P.A. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383 (1996) 407-413
5. Hebrok M. Hedgehog signaling in pancreas development. Mech. Dev. 120 (2003) 45-57
6. Hebrok M., Kim S.K., and Melton D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 12 (1998) 1705-1713
7. Bale A.E., and Yu K.P. The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 10 (2001) 757-762
8. Wechsler-Reya R., and Scott M.P. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24 (2001) 385-428
9. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., and Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422 (2003) 313-317
10. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., and Beachy P.A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425 (2003) 846-851
11. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., and Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (2003) 851-856
12. Ellenrieder V., Adler G., and Gress T.M. Invasion and metastasis in pancreatic cancer. Ann. Oncol. 10 Suppl. 4 (1999)
13. Duffy M.J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis 10 (1992) 145-155
14. Polgar L. Common feature of the four types of protease mechanism. Biol. Chem. Hoppe Seyler 371 Suppl. (1990) 327-331
15. Szpaderska A.M., and Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61 (2001) 3493-3500
16. Thomssen C., Schmitt M., Goretzki L., Oppelt P., Pache L., Dettmar P., Janicke F., and Graeff H. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin. Cancer Res. 1 (1995) 741-746
17. Shuja S., Sheahan K., and Murnane M.J. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer 49 (1991) 341-346
18. Herszenyi L., Plebani M., Carraro P., De Paoli M., Roveroni G., Cardin R., Foschia F., Tulassay Z., Naccarato R., and Farinati F. Proteases in gastrointestinal neoplastic diseases. Clin. Chim. Acta 291 (2000) 171-187
19. Niedergethmann M., Wostbrock B., Sturm J.W., Willeke F., Post S., and Hildenbrand R. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 29 (2004) 204-211
20. Yang S.H., Kim J.S., Oh T.J., Kim M.S., Lee S.W., Woo S.K., Cho H.S., Choi Y.H., Kim Y.H., Rha S.Y., Chung H.C., and An S.W. Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int. J. Oncol. 22 (2003) 741-750
21. Lee H.S., Lee H.K., Kim H.S., Yang H.K., and Kim W.H. Tumour suppressor gene expression correlates with gastric cancer prognosis. J. Pathol. 200 (2003) 39-46
22. Castiglioni T., Merino M.J., Elsner B., Lah T.T., Sloane B.F., and Emmert-Buck M.R. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum. Pathol. 25 (1994) 857-862
23. Poole A.R., Tiltman K.J., Recklies A.D., and Stoker T.A. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273 (1978) 545-547
24. Bervar A., Zajc I., Sever N., Katunuma N., Sloane B.F., and Lah T.T. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biol. Chem. 384 (2003) 447-455
25. Werle B., Lotterle H., Schanzenbacher U., Lah T.T., Kalman E., Kayser K., Bulzebruck H., Schirren J., Krasovec M., Kos J., and Spiess E. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. Br. J. Cancer 81 (1999) 510-519
26. Fujise N., Nanashim A., Taniguchi Y., Matsuo S., Hatano K., Matsumoto Y., Tagawa Y., and Ayabe H. Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study. Lung Cancer 27 (2000) 19-26
27. Nakae T., Horai T., Imamura F., Akedo H., and Higashino K. Expression of cathepsin B in small cell lung carcinoma cells in relation to in vitro invasiveness. Tumour Biol. 19 (1998) 118-125
28. Rempel S.A., Rosenblum M.L., Mikkelsen T., Yan P.S., Ellis K.D., Golembieski W.A., Sameni M., Rozhin J., Ziegler G., and Sloane B.F. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54 (1994) 6027-6031
29. Strojnik T., Kos J., Zidanik B., Golouh R., and Lah T. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin. Cancer Res. 5 (1999) 559-567
30. Watanabe M., Higashi T., Watanabe A., Osawa T., Sato Y., Kimura Y., Tominaga S., Hashimoto N., Yoshida Y., Morimoto S., et al. Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. Biochem. Med. Metab. Biol. 42 (1989) 21-29
31. Czyzewska J., Guzinska-Ustymowicz K., Kemona A., and Bandurski R. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival. Folia Histochem. Cytobiol. 46 (2008) 57-64
32. Liu Y., Xiao S., Shi Y., Wang L., Ren W., and Sloane B.F. Cathepsin B on invasion and metastasis of gastric carcinoma. Chin. Med. J 111 (1998) 784-788
33. Ebert M.P., Kruger S., Fogeron M.L., Lamer S., Chen J., Pross M., Schulz H.U., Lage H., Heim S., Roessner A., Malfertheiner P., and Rocken C. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 5 (2005) 1693-1704
34. Sinha A.A., Gleason D.F., Staley N.A., Wilson M.J., Sameni M., and Sloane B.F. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat. Rec. 241 (1995) 353-362
35. Frohlich E., Schlagenhauff B., Mohrle M., Weber E., Klessen C., and Rassner G. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 91 (2001) 972-982
36. Kos J., Stabuc B., Schweiger A., Krasovec M., Cimerman N., Kopitar-Jerala N., and Vrhovec I. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3 (1997) 1815-1822
37. Hu W.G., Liu T., Xiong J.X., and Wang C.Y. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells. Acta Pharmacol. Sin. 28 (2007) 1224-1230
38. Chung S.M., and Kawai K. Variant cathepsin B activity secreted from human pancreatic cancer cell lines into protein-free chemically defined medium. Gastroenterol. Jpn. 24 (1989) 699-706
39. Tzanakakis G.N., Margioris A.N., Tsatsakis A.M., and Vezeridis M.P. The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity. Int. J. Gastrointest. Cancer 34 (2003) 27-38